Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BAY TANDLÆGE OG IMPLANTATKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.8% 4.7% 5.7% 2.0% 3.4% 1.5% 7.1% 7.1%   Credit score (0-100)   61 47 40 67 54 76 34 34   Credit rating   BBB BBB BBB A BBB A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.5 0.0 31.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,658 5,460 5,694 6,553 6,964 8,200 0.0 0.0   EBITDA   1,318 554 554 1,411 808 1,990 0.0 0.0   EBIT   442 -168 -168 876 317 1,470 0.0 0.0   Pre-tax profit (PTP)   124.1 -527.7 -527.7 665.1 96.0 1,253.0 0.0 0.0   Net earnings   73.6 -445.9 -445.9 518.5 78.9 980.2 0.0 0.0   Pre-tax profit without non-rec. items   124 -528 -528 665 96.0 1,253 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,063 1,116 1,116 1,635 1,703 1,617 0.0 0.0   Shareholders equity total   1,168 1,120 1,120 1,525 1,490 2,352 2,105 2,105   Interest-bearing liabilities   1,385 251 0.0 254 0.0 0.3 0.0 0.0   Balance sheet total (assets)   6,460 5,108 5,108 4,648 6,063 5,887 2,105 2,105   Net Debt   1,378 -125 -375 -1,100 -2,816 -2,698 -1,168 -1,168     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,658 5,460 5,694 6,553 6,964 8,200 0.0 0.0   Gross profit growth   -6.4% -3.5% 4.3% 15.1% 6.3% 17.8% -100.0% 0.0%   Employees   9 10 10 10 9 9 0 0   Employee growth %   0.0% 11.1% 0.0% 0.0% -10.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,460 5,108 5,108 4,648 6,063 5,887 2,105 2,105   Balance sheet change%   21.9% -20.9% 0.0% -9.0% 30.5% -2.9% -64.2% 0.0%   Added value   1,318.0 554.1 554.1 1,410.8 852.1 1,990.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -836 -1,849 -722 -107 -514 -697 -1,617 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.8% -3.1% -2.9% 13.4% 4.6% 17.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.6% -4.0% -4.5% 18.1% 6.1% 24.7% 0.0% 0.0%   ROI %   16.7% -8.6% -11.3% 43.3% 16.2% 65.0% 0.0% 0.0%   ROE %   6.2% -39.0% -39.8% 39.2% 5.2% 51.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.1% 22.0% 20.9% 32.8% 24.6% 40.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   104.5% -22.5% -67.7% -78.0% -348.3% -135.6% 0.0% 0.0%   Gearing %   118.6% 22.4% 0.0% 16.6% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   37.1% 36.3% 236.9% 171.5% 180.7% 177,326.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.8 0.8 0.7 0.7 1.0 0.0 0.0   Current Ratio   0.6 0.9 0.8 0.7 0.8 1.0 0.0 0.0   Cash and cash equivalent   7.1 375.3 375.3 1,353.6 2,816.0 2,698.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,745.0 -256.0 -506.5 -691.4 -983.5 37.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   146 55 55 141 95 221 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   146 55 55 141 90 221 0 0   EBIT / employee   49 -17 -17 88 35 163 0 0   Net earnings / employee   8 -45 -45 52 9 109 0 0